# BRT Apartments Corp.: financial statements, quarterly

BRT · NYSE · CIK 14846 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brt.md) · [Financials](/companies/brt/financials.md) · [Filings](/companies/brt/filings.md) · [Insiders](/companies/brt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/brt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [23.9](/filings/0000014846-25-000005.md) | [23.5](/filings/0000014846-25-000005.md) | [23.4](/filings/0000014846-25-000012.md) | [23.9](/filings/0000014846-25-000027.md) | [24.4](/filings/0000014846-25-000037.md) | [24.0](/filings/0000014846-25-000005.md) | [24.1](/filings/0000014846-26-000017.md) | [24.2](/filings/0000014846-26-000037.md) | [24.4](/filings/0000014846-25-000037.md) | [24.3 d](/filings/0000014846-26-000007.md) | [24.6](/filings/0000014846-26-000017.md) | [24.5](/filings/0000014846-26-000037.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(2.9)](/filings/0000014846-25-000005.md) | [(2.2)](/filings/0000014846-25-000005.md) | [(3.3)](/filings/0000014846-25-000012.md) | [(2.8)](/filings/0000014846-25-000027.md) | [(2.8)](/filings/0000014846-25-000037.md) | [(3.4)](/filings/0000014846-25-000005.md) | [(2.7)](/filings/0000014846-26-000017.md) | [(3.0)](/filings/0000014846-26-000037.md) | [(3.3)](/filings/0000014846-25-000037.md) | [(3.5) d](/filings/0000014846-26-000007.md) | [(2.4)](/filings/0000014846-26-000017.md) | [(3.1)](/filings/0000014846-26-000037.md) |
| Income tax | $m | [(0.1)](/filings/0000014846-25-000005.md) | [0.0](/filings/0000014846-25-000005.md) | [0.1](/filings/0000014846-25-000012.md) | [(0.1)](/filings/0000014846-25-000027.md) | [(0.3)](/filings/0000014846-25-000037.md) | [0.1](/filings/0000014846-25-000005.md) | [0.1](/filings/0000014846-26-000017.md) | [0.1](/filings/0000014846-26-000037.md) | [0.0](/filings/0000014846-25-000037.md) | [0.1 d](/filings/0000014846-26-000007.md) | [0.1](/filings/0000014846-26-000017.md) | [0.0](/filings/0000014846-26-000037.md) |
| Net income | $m | [(1.5)](/filings/0000014846-25-000005.md) | [(1.7)](/filings/0000014846-25-000005.md) | [(3.2)](/filings/0000014846-25-000012.md) | [(2.3)](/filings/0000014846-25-000027.md) | [(2.2)](/filings/0000014846-25-000037.md) | [(2.1)](/filings/0000014846-25-000005.md) | [(2.4)](/filings/0000014846-26-000017.md) | [(2.6)](/filings/0000014846-26-000037.md) | [(2.7)](/filings/0000014846-25-000037.md) | [(4.3) d](/filings/0000014846-26-000007.md) | [(2.7)](/filings/0000014846-26-000017.md) | [(3.2)](/filings/0000014846-26-000037.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0000014846-25-000005.md) | [(0.11)](/filings/0000014846-25-000005.md) | [(0.17)](/filings/0000014846-25-000012.md) | [(0.13)](/filings/0000014846-25-000027.md) | [(0.12)](/filings/0000014846-25-000037.md) | [(0.11)](/filings/0000014846-25-000005.md) | [(0.12)](/filings/0000014846-26-000017.md) | [(0.14)](/filings/0000014846-25-000027.md) | [(0.14)](/filings/0000014846-25-000037.md) | not reported | [(0.14)](/filings/0000014846-26-000017.md) | not reported |
| Basic EPS | $ per share | [(0.08)](/filings/0000014846-25-000005.md) | [(0.11)](/filings/0000014846-25-000005.md) | [(0.17)](/filings/0000014846-25-000012.md) | [(0.13)](/filings/0000014846-25-000027.md) | [(0.12)](/filings/0000014846-25-000037.md) | [(0.11)](/filings/0000014846-25-000005.md) | [(0.12)](/filings/0000014846-26-000017.md) | [(0.14)](/filings/0000014846-25-000027.md) | [(0.14)](/filings/0000014846-25-000037.md) | not reported | [(0.14)](/filings/0000014846-26-000017.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [28.1](/filings/0000014846-24-000061.md) | [23.5](/filings/0000014846-25-000005.md) | [21.3](/filings/0000014846-25-000012.md) | [18.9](/filings/0000014846-25-000027.md) | [45.8](/filings/0000014846-25-000037.md) | [27.9](/filings/0000014846-26-000007.md) | [24.4](/filings/0000014846-26-000017.md) | [23.6](/filings/0000014846-26-000037.md) | [21.1](/filings/0000014846-25-000037.md) | [25.1](/filings/0000014846-26-000037.md) | [26.9](/filings/0000014846-26-000017.md) | [22.7](/filings/0000014846-26-000037.md) |
| Total assets | $m | [721](/filings/0000014846-23-000040.md) | [710](/filings/0000014846-25-000005.md) | [699](/filings/0000014846-24-000027.md) | [695](/filings/0000014846-24-000050.md) | [718](/filings/0000014846-24-000061.md) | [713](/filings/0000014846-26-000007.md) | [704](/filings/0000014846-25-000012.md) | [700](/filings/0000014846-25-000027.md) | [714](/filings/0000014846-25-000037.md) | [710](/filings/0000014846-26-000037.md) | [698](/filings/0000014846-26-000017.md) | [691](/filings/0000014846-26-000037.md) |
| Total liabilities | $m | [484](/filings/0000014846-23-000040.md) | [482](/filings/0000014846-25-000005.md) | [479](/filings/0000014846-24-000027.md) | [480](/filings/0000014846-24-000050.md) | [508](/filings/0000014846-24-000061.md) | [509](/filings/0000014846-26-000007.md) | [506](/filings/0000014846-25-000012.md) | [508](/filings/0000014846-25-000027.md) | [528](/filings/0000014846-25-000037.md) | [533](/filings/0000014846-26-000037.md) | [529](/filings/0000014846-26-000017.md) | [531](/filings/0000014846-26-000037.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [237](/filings/0000014846-23-000040.md) | [228](/filings/0000014846-25-000005.md) | [221](/filings/0000014846-24-000027.md) | [215](/filings/0000014846-24-000050.md) | [210](/filings/0000014846-24-000061.md) | [205](/filings/0000014846-26-000007.md) | [198](/filings/0000014846-25-000012.md) | [192](/filings/0000014846-25-000027.md) | [187](/filings/0000014846-25-000037.md) | [177](/filings/0000014846-26-000037.md) | [169](/filings/0000014846-26-000017.md) | [160](/filings/0000014846-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [9,323 d](/filings/0000014846-24-000061.md) | [3,937 d](/filings/0000014846-25-000005.md) | [653](/filings/0000014846-25-000012.md) | [6,941 d](/filings/0000014846-25-000027.md) | [8,968 d](/filings/0000014846-25-000037.md) | [7,581 d](/filings/0000014846-26-000007.md) | [246](/filings/0000014846-26-000017.md) | [8,478 d](/filings/0000014846-26-000037.md) | [9,054 d](/filings/0000014846-25-000037.md) | [(3,680) d](/filings/0000014846-26-000007.md) | [2,086](/filings/0000014846-26-000017.md) | [6,336 d](/filings/0000014846-26-000037.md) |
| Dividends paid | $k | [4,730 d](/filings/0000014846-24-000061.md) | [4,658 d](/filings/0000014846-25-000005.md) | [4,624](/filings/0000014846-25-000012.md) | [4,646 d](/filings/0000014846-25-000027.md) | [4,679 d](/filings/0000014846-25-000037.md) | [4,690 d](/filings/0000014846-26-000007.md) | [4,698](/filings/0000014846-26-000017.md) | [4,731 d](/filings/0000014846-26-000037.md) | [4,726 d](/filings/0000014846-25-000037.md) | [4,739 d](/filings/0000014846-26-000007.md) | [984](/filings/0000014846-26-000017.md) | [4,693 d](/filings/0000014846-26-000037.md) |
| Share repurchases | $k | [4,950 d](/filings/0000014846-24-000061.md) | [3,613 d](/filings/0000014846-25-000005.md) | [2,267](/filings/0000014846-25-000012.md) | [930 d](/filings/0000014846-25-000027.md) | [115 d](/filings/0000014846-25-000037.md) | [183 d](/filings/0000014846-26-000007.md) | [1,382](/filings/0000014846-26-000017.md) | [1,004 d](/filings/0000014846-26-000037.md) | [0.0 d](/filings/0000014846-25-000037.md) | [2,601 d](/filings/0000014846-26-000007.md) | [2,512](/filings/0000014846-26-000017.md) | [2,896 d](/filings/0000014846-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.0](/filings/0000014846-23-000040.md) | [18.1](/filings/0000014846-24-000027.md) | [18.2](/filings/0000014846-24-000050.md) | [17.9](/filings/0000014846-24-000061.md) | [17.6](/filings/0000014846-25-000012.md) | [17.7](/filings/0000014846-25-000027.md) | [17.8](/filings/0000014846-25-000037.md) | [18.0](/filings/0000014846-26-000017.md) | [18.0](/filings/0000014846-26-000037.md) | [18.0](/filings/0000014846-25-000037.md) | [18.1](/filings/0000014846-26-000017.md) | [18.0](/filings/0000014846-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,793,277 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0000014846-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.